Literature DB >> 23467598

Rothia mucilaginosa prosthetic device infections: a case of prosthetic valve endocarditis.

Jackrapong Bruminhent1, Mindy J Tokarczyk, Donald Jungkind, Joseph A DeSimone.   

Abstract

Rothia mucilaginosa is increasingly recognized as an emerging opportunistic pathogen associated with prosthetic device infections. Infective endocarditis is one of the most common clinical presentations. We report a case of R. mucilaginosa prosthetic valve endocarditis and review the literature of prosthetic device infections caused by this organism.

Entities:  

Mesh：

Year:  2013        PMID： 23467598      PMCID： PMC3647895          DOI： 10.1128/JCM.03173-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  21 in total

Review 1.  Miscellaneous catalase-negative, gram-positive cocci: emerging opportunists.

Authors:  Kathryn L Ruoff
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

2.  Septic arthritis due to Rothia mucilaginosa.

Authors:  A J Kaasch; G Saxler; H Seifert
Journal:  Infection       Date:  2010-12-03       Impact factor: 3.553

Review 3.  Prosthetic-joint infections.

Authors:  Werner Zimmerli; Andrej Trampuz; Peter E Ochsner
Journal:  N Engl J Med       Date:  2004-10-14       Impact factor: 91.245

4.  Stomatococcus mucilaginosus prosthetic valve endocarditis.

Authors:  H L Lazar; C Sulis; W Hauser
Journal:  J Thorac Cardiovasc Surg       Date:  1988-05       Impact factor: 5.209

5.  Endocarditis caused by relatively penicillin-resistant Stomatococcus mucilaginosus.

Authors:  R L Pinsky; V Piscitelli; J E Patterson
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

Review 6.  Pathobiology of infection in prosthetic devices.

Authors:  S H Dougherty
Journal:  Rev Infect Dis       Date:  1988 Nov-Dec

7.  Stomatococcus mucilaginosus bacteremias. Typical case presentations, simplified diagnostic criteria, and a literature review.

Authors:  P S Mitchell; B J Huston; R N Jones; L Holcomb; F P Koontz
Journal:  Diagn Microbiol Infect Dis       Date:  1990 Nov-Dec       Impact factor: 2.803

8.  Isolation of Stomatococcus mucilaginosus from drug user with endocarditis.

Authors:  P E Coudron; S M Markowitz; L B Mohanty; P F Schatzki; J M Payne
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

9.  Association of Stomatococcus mucilaginosus with cholangitis.

Authors:  V P Harjola; M Valtonen; A Sivonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-07       Impact factor: 3.267

Review 10.  Cerebral mycotic aneurysm complicating Stomatococcus mucilaginosus infective endocarditis.

Authors:  Cesar Pérez-Vega; Javier Narváez; Gemma Calvo; Francisco J Castro-Bohorquez; María Teresa Falgueras; Jaime Vilaseca-Momplet
Journal:  Scand J Infect Dis       Date:  2002
View more
  4 in total

1.  Rothia bacteremia: a 10-year experience at Mayo Clinic, Rochester, Minnesota.

Authors:  Poornima Ramanan; Jason N Barreto; Douglas R Osmon; Pritish K Tosh
Journal:  J Clin Microbiol       Date:  2014-06-20       Impact factor: 5.948

2.  The Difference of Gut Microbiota and Their Correlations With Urinary Organic Acids Between Autistic Children With and Without Atopic Dermatitis.

Authors:  Ru-Ping Hong; Yue-Ying Hou; Xin-Jie Xu; Ji-Dong Lang; Yun-Feng Jin; Xiao-Feng Zeng; Xuan Zhang; Geng Tian; Xin You
Journal:  Front Cell Infect Microbiol       Date:  2022-06-21       Impact factor: 6.073

3.  First Report of Acute Postoperative Endophthalmitis Caused by Rothia Mucilaginosa after Phacoemulsification.

Authors:  Pablo Álvarez-Ramos; Amparo Del Moral-Ariza; José M Alonso-Maroto; Pilar Marín-Casanova; José M Calandria-Amigueti; Manuel Rodríguez-Iglesias; Enrique Rodríguez de la Rúa
Journal:  Infect Dis Rep       Date:  2016-03-21

4.  Identification of Emerging Human Mastitis Pathogens by MALDI-TOF and Assessment of Their Antibiotic Resistance Patterns.

Authors:  María Marín; Rebeca Arroyo; Irene Espinosa-Martos; Leónides Fernández; Juan M Rodríguez
Journal:  Front Microbiol       Date:  2017-07-12       Impact factor: 5.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.